Aztherapiesincis A Private Biopharmaceutical Company Based In Bostonmassachusettsthe Company Is Dedicated To Developing Innovative Therapies That Target Neurodegenerative Diseaseswith A Particular Focus On Neuroinflammation As A Key Factor In Disease Progression The Company S Lead Candidatealzt Op1Is Currently In Phase 3 Clinical Trials For Early Alzheimerae S Diseaseaztherapies Is Also Advancing Treatments For Amyotrophic Lateral Sclerosisalsand Cognitive Impairments Following Ischemic Strokeadditionallythey Are Exploring A Car Treg Program That May Have Applications Across Various Neurodegenerative Conditionsaztherapies Has Successfully Raised Significant Fundingincluding A $33 6 Million Series C 1 Financing Round In 2020Building On Earlier Investments To Support Their Research And Development Efforts
